ABSTRACT
OBJECTIVE@#To investigate the proper dosage of heparin and protamin in treating the patients with infective endocarditis (IE) during the operation.@*METHODS@#Activated clotting time (ACT) was measured during and after cardiopulmonary bypass (CPB) in 30 patients with IE and 30 patients with rheumatic heart disease (RHD) respectively.@*RESULTS@#The dosage of heparin before bypass in IE group was significantly higher than that of RHD group (P0.05).@*CONCLUSION@#The dosage of protamin should be increased to 3 mg/kg as the heparin is over 400 U/kg before CPB in the patient with IE, but the ratio of protamin and heparin will not be obviously changed.
Subject(s)
Adult , Female , Humans , Male , Middle Aged , Anticoagulants , Therapeutic Uses , Cardiopulmonary Bypass , Dose-Response Relationship, Drug , Drug Monitoring , Methods , Endocarditis , General Surgery , Heparin , Therapeutic Uses , Heparin Antagonists , Therapeutic Uses , Intraoperative Care , Methods , Protamines , Therapeutic Uses , Whole Blood Coagulation TimeABSTRACT
OBJECTIVE@#To create a method for transfecting human vascular endothelial growth factor165 (hVEGF165) gene into bone marrow mesenchymal stem cells (MSCs) in rats.@*METHODS@#MSCs of Wistar rats were isolated by density gradient centrifugation and purified based on their ability of adhesion to plastic. Detections of cell surface antigens, including CD34, CD45, CD44, and SH3, were performed using flow cytometry. MSCs' potential of differentiating into osteoblast and lipoblast in vitro was tested. The vector pcDNA(3.1)-hVEGF165 was transfected into MSCs with the liposome mediated method. The expression of hVEGF165 in the transfected cells was detected by enzyme linked immunosorbent assay (ELISA), reverse transcription-polymerase chain reaction (RT-PCR), and Western blot analysis.@*RESULTS@#The cultured MSCs were CD34-, CD45-, CD44+ , and SH+, which were differentiated into osteoblasts and lipocytes successfully. The expressed hVEGF165 in the transfected rat MSCs was demonstrated.@*CONCLUSION@#The vector pcDNA(3.1)-hVEGF165 is successfully expressed in MSCs.